Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes
- 1 November 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (11) , 2006-2010
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 29 references indexed in Scilit:
- Detection and quantification of residual disease in chronic myelogenous leukemiaLeukemia, 2000
- Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogeneticsBritish Journal of Haematology, 1999
- Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCRLeukemia, 1999
- Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assayLeukemia, 1999
- A polymorphism in exon b2 of the major breakpoint cluster region (M‐bcr) identified in chronic myeloid leukaemia patientsBritish Journal of Haematology, 1998
- Molecular response of CML patients treated with interferon‐α monitored by quantitative Southern blot analysisBritish Journal of Haematology, 1997
- Product Differentiation by Analysis of DNA Melting Curves during the Polymerase Chain ReactionAnalytical Biochemistry, 1997
- Kinetic Selectivity of Complementary Nucleic Acids:bcr-abl-directed Antisense RNA and RibozymesJournal of Molecular Biology, 1996
- Sequence and Analysis of the Human ABL Gene, the BCR Gene, and Regions Involved in the Philadelphia Chromosomal TranslocationGenomics, 1995
- Structural organization of the bcr gene and its role in the Ph′ translocationNature, 1985